XIAP and melanoma: Experience from larger series of ILP for the treatment of sarcoma and melanoma indicate that the mortality rate associated with ILP is less than 1%15–17,31–34 Of interest, both patients were classified as American Society of Anesthesiologists physical status classification  (ASA)—three patients, and both patients were treated in the early stages of this ILP treatment.